Skip to content

Application of the Triple Stimulation Technique to Patients With CNS Disorders Including Stroke

Application of the Triple Stimulation Technique to Patients With CNS Disorders Including Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02354248
Enrollment
100
Registered
2015-02-03
Start date
2014-06-11
Completion date
2016-09-13
Last updated
2018-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke Patients

Keywords

TST, TMS, Stroke patients, EMG

Brief summary

TST (Triple stimulation technique) helps to better quantify the proportion of motor units activated by transcranial magnetic stimulation. The abnormal amplitude registered by TST is proportional to the intensity of conduction disorders. The evaluation of these disorders is more precise with this technique than with the slowing of the central conduction time (CCT). The investigators propose to use this technique in CNS pathologies where this disorder is significant and essential, like multiple sclerosis and stroke.

Interventions

Evoked motor potentials obtained by magnetic transcranial stimulation are usually used, in standard practice, to evaluate the corticospinal tract. This procedure combines two techniques: the magnetic stimulation and the electroneuromyography. It is based on the double collision principle between the descending central stimulation (magnetic) and the ascending peripheric stimulation, hereby suppressing the issue of desynchronisation of evoked motor potentials. The Triple stimulation technique allows a better quantification of the proportion of motor units activated by the transcranial stimulation.

Sponsors

Brugmann University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* stroke patients with hemiparesia

Exclusion criteria

* pace maker * epilepsia * metallic neurosurgical implants

Design outcomes

Primary

MeasureTime frame
Amplitude of the motor evoked potentialsduring the TST (30 min)
Surface of the motor evoked potentialsduring the TST (30 min)
Amplitude ratio of the TSTduring the TST (30 min)
Surface ratio of the TSTduring the TST (30 min)
TMS thresholdduring TST (30 min)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026